Trueblood Wealth Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.84M Buy
12,532
+452
+4% +$81.9K 0.64% 43
2026
Q1
$1.78M Sell
12,080
-1,698
-12% -$276K 0.7% 36
2025
Q4
$2.69M Buy
13,778
+8
+0.1% +$1.91K 1.05% 13
2025
Q3
$3.87M Sell
13,770
-243
-2% -$61.9K 1.51% 5
2025
Q2
$3.06M Buy
14,013
+364
+3% +$58.8K 1.28% 10
2025
Q1
$1.91M Buy
13,649
+953
+8% +$155K 0.89% 21
2024
Q4
$2.12M Buy
12,696
+2
+0% +$355 1.04% 16
2024
Q3
$2.16M Buy
12,694
+443
+4% +$64.2K 1.09% 14
2024
Q2
$1.73M Buy
12,251
+101
+0.8% +$12.5K 0.98% 18
2024
Q1
$1.53M Sell
12,150
-471
-4% -$53.9K 0.87% 25
2023
Q4
$1.33M Buy
+12,621
New +$1.38M 0.83% 27

Other funds holding ORCL

Trueblood Wealth Management's ORCL Position: Q2 2026 in Review

Trueblood Wealth Management increased its Oracle (ORCL) stake by 3.7% in Q2 2026, buying an estimated $81.9K and bringing the position to 12,532 shares worth $1.84M. The position accounts for 0.64% of the portfolio, ranked #43.

Trueblood Wealth Management first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.87M in Q3 2025. 1,681 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Trueblood Wealth Management held 12,532 shares of Oracle worth $1.84M as of Q2 2026.
  • Trueblood Wealth Management bought 452 Oracle shares in Q2 2026, an estimated $81.9K.
  • Oracle made up 0.64% of Trueblood Wealth Management's portfolio in Q2 2026, its #43 holding.
  • Trueblood Wealth Management first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Oracle position peaked at $3.87M in Q3 2025.
  • 1,681 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.